As a core resource supported by NCI, the overall goals of the UNM Fluorescence Microscopy Resource are to provide: a) support services through user access to state-of-the art facilities and technologies, b) user training and individualized support or collaboration to address cancer relevant questions, c) innovation through the testing and development of new probes and imaging technologies, d) dissemination through resource tours, poster displays, an annual open house, workshops and a web page. The UNM Fluorescence Microscopy and Cell Imaging Shared Resource offers complete fluorescence microscopic imaging services including ratiometric imaging of ions, deconvolufion, confocal, hyperspectral and convenfional light microscopic imaging of live and fixed samples. Fee for service charges are in line with mid-range nation-wide rates and UNM Cancer Center members benefit from a 20% copay. The Resource is centrally located in four rooms on the second floor of the Cancer Research Facility. Instrumentafion is regularly upgraded through a mix of extramural (NCRR, NCI) and intramural (UNM SOM and Cancer Center) funding. Current instruments include upright and inverted Zeiss, Nikon and Olympus microscopes fitted with Zeiss LSM 510, Zeiss META and BioRad Radiance confocal scanheads and TillVision ratiometric system. CRi Nuance, Andor iXon, Orca and Zeiss digital cameras offer low light sensitivity and spectral image collecfion on widefield instruments. Up to eight color imaging, FRET and FRAP can be performed on the Zeiss META and mulfiple software packages allow quantitative evaluafion of all collected data. A stereology and spinning disk system will be installed in 2009. Infrequent users may request full service imaging by one of the expert staff members. The Resource is acfively involved in educafion by providing tours, hosfing extramural speakers, new user training, annual open house meefings and hands-on workshops. Cancer Center members using the Resource encompass 29 research groups, representing all four Cancer Center research programs, and account for >60% total use. Value added for Cancer Center members is evidenced by 22 publicafions, journal cover pictures (CY08) and 31 extramural projects (12 NCI, ACS or LLS) using the Resource in the reporting period (FY09). Seminal discoveries pertinent to oncogenic virus entry, G-coupled receptor function, DNA damage and repair, intracellular signaling, mechanisms of endocytosis, and biotechnology development have been enabled by the Resource.

Public Health Relevance

The UNM Cancer Center houses expensive instrumentation such as sensitive digital cameras and laser scanning microscopes. The instruments are maintained within a core facility with expert staff and enable basic and physician researchers to discover how cancer causing viruses enter cells or how UV and chemical injury leads to DNA damage and cancer, as well as to evaluate therapeutic efficacy in cells and patient samples and accelerate therapeutic development through biotechnology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA118100-08
Application #
8379126
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
8
Fiscal Year
2012
Total Cost
$52,278
Indirect Cost
Name
University of New Mexico Health Sciences Center
Department
Type
DUNS #
829868723
City
Albuquerque
State
NM
Country
United States
Zip Code
87131
Lin, Jia; Wester, Michael J; Graus, Matthew S et al. (2016) Nanoscopic cell-wall architecture of an immunogenic ligand in Candida albicans during antifungal drug treatment. Mol Biol Cell 27:1002-14
Termini, Christina M; Lidke, Keith A; Gillette, Jennifer M (2016) Tetraspanin CD82 Regulates the Spatiotemporal Dynamics of PKCα in Acute Myeloid Leukemia. Sci Rep 6:29859
Kerketta, Romica; Halász, Ádám M; Steinkamp, Mara P et al. (2016) Effect of Spatial Inhomogeneities on the Membrane Surface on Receptor Dimerization and Signal Initiation. Front Cell Dev Biol 4:81
Gage, Julia C; Hunt, William C; Schiffman, Mark et al. (2016) Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program. Cancer Epidemiol Biomarkers Prev 25:36-42
Brayer, Kathryn J; Frerich, Candace A; Kang, Huining et al. (2016) Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma. Cancer Discov 6:176-87
Meyer, Matthias R; Fredette, Natalie C; Daniel, Christoph et al. (2016) Obligatory role for GPER in cardiovascular aging and disease. Sci Signal 9:ra105
Winner, Kimberly R Kanigel; Steinkamp, Mara P; Lee, Rebecca J et al. (2016) Spatial Modeling of Drug Delivery Routes for Treatment of Disseminated Ovarian Cancer. Cancer Res 76:1320-34
Hoffman, Richard M; Meisner, Angela L W; Arap, Wadih et al. (2016) Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995-2012. Cancer Epidemiol Biomarkers Prev 25:259-63
Dobroff, Andrey S; D'Angelo, Sara; Eckhardt, Bedrich L et al. (2016) Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes. Proc Natl Acad Sci U S A :
Castillo, Eliseo F; Ray, Anita L; Beswick, Ellen J (2016) MK2: an unrecognized regulator of tumor promoting macrophages in colorectal cancer? Macrophage (Houst) 3:

Showing the most recent 10 out of 222 publications